Vext Science (FRA:VV5) Graham Number: €N/A (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VV5 Vext Science Inc FRA:VV5
55 GF Score
Price €0.16
GF Value €1.01
! 4 Warning Signs
View Full Analysis

What is Vext Science Graham Number?

Vext Science FRA:VV5 -0.61% 55 Graham Number is €N/A as of Mar. 2026. GuruFocus rates FRA:VV5 with a GF Score™ of 55/100 and a GF Value™ of €1.01. The stock has 4 warning signs investors should review. Among 601 Drug Manufacturers companies, Vext Science ranks worse than 166389.18% on this metric.

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2026-08-21), the stock price of Vext Science is €0.164. Vext Science's graham number for the quarter that ended in Mar. 2026 was €N/A. Therefore, Vext Science's Price to Graham Number ratio for today is N/A.

The historical rank and industry rank for Vext Science's Graham Number or its related term are showing as below:

During the past 9 years, the highest Price to Graham Number ratio of Vext Science was 1.87. The lowest was 0.24. And the median was 0.62.

FRA:VV5's Price-to-Graham-Number is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.57
* Ranked among companies with meaningful Price-to-Graham-Number only.

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Vext Science  (FRA:VV5) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Vext Science's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Mar. 2026 )
=0.164/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Vext Science Graham Number Related Terms


Vext Science Graham Number Historical Data

* Premium members only.

The historical data trend for Vext Science's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science Graham Number Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Graham Number
Get a 7-Day Free Trial Premium Member Only 0.46 0.69 0.00 0.00 0.00

Vext Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:VV5 vs ZTS: Graham Number Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science Price-to-Graham-Number vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Vext Science's Price-to-Graham-Number falls into.


FRA:VV5
55GF Score
Vext Science Inc FRA:VV5
Graham Number is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vext Science Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Vext Science's Graham Number for the fiscal year that ended in Dec. 2025 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*-0.034*-0.047)
=N/A

Vext Science's Graham Number for the quarter that ended in Mar. 2026 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*-0.031*-0.04)
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Graham Number →
What does a Graham Number of €N/A mean?
Vext Science (FRA:VV5) has a Graham Number of €N/A as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Vext Science and its competitors. Over the past decade, Vext Science's Graham Number has ranged from 0.24 to 1.87. According to the industry distribution chart, Vext Science ranks #999999 out of 601 companies in the Drug Manufacturers industry.
Is Vext Science's Graham Number too high?
Vext Science's current Graham Number is €N/A. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 1.87. Based on the distribution chart, Vext Science ranks #999999 out of 601 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vext Science has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Vext Science's Graham Number compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vext Science ranks #999999 out of 601 companies for Graham Number. This places Vext Science in the lower half of its industry. The industry median Graham Number is 1.57. Historically, Vext Science's own Graham Number has ranged from 0.24 to 1.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Drug Manufacturers company?
The median Graham Number among Drug Manufacturers companies is 1.57, based on 601 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Vext Science and its competitors. For the Drug Manufacturers industry, the median Graham Number is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vext Science's current Graham Number is €N/A. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Vext Science (FRA:VV5) has a current Graham Number of €N/A. The stock's GF Value™ is €1.01, compared to a current price of €0.16 — trading 83.8% below its estimated fair value. The current Graham Number is €N/A. Vext Science's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Vext Science (FRA:VV5), the current Graham Number is €N/A as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vext Science (FRA:VV5) Overvalued in 2026?

Based on GuruFocus' analysis, Vext Science stock appears to be undervalued. The current stock price of €0.16 is trading 83.8% below its estimated GF Value™ of €1.01.

Key valuation signals for FRA:VV5:

  • Graham Number: €N/A
  • GF Value™: €1.01 vs. price of €0.16 (83.8% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the FRA:VV5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vext Science Business Description

Other Exchanges VEXTF:USAVEXT:Canada
Address 4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
55GF Score

Get the complete analysis for FRA:VV5

Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.16
Price
€1.01
GF Value